Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for ...

Havah Therapeutics today, announced that the United States Patent and Trademark Office (USPTO) has granted a new patent (US Patent No. 12,128,055) for its innovative T+Ai combination therapy?a novel ...

Havah Therapeutics today, announced that the United States Patent and Trademark Office (USPTO) has granted a new patent (US Patent No. 12,128,055) for its innovative T+Ai combination therapy—a novel ...

Tharimmune, Inc. (NASDAQ:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today ...

On October 17, 2024, Adial announced that the United States Patent and Trademark Office has issued a Notice of Allowance for a new patent. The patent, once issued, will cover additional genotype ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...

ConnexPay’s patent, U.S. Patent No. 12,118,519 granted by the United States Patent and Trademark Office, is titled ...

The festive season, spanning October to December, is bolstering BluSmart’s performance, with projections indicating a 50% ...

A federal judge's dismissal of a copyright claim against OpenAI has artists and writers wondering if they can ever win in ...

A recent executive order prompted the US Patent and Trademark Office to publish a new guideline in July 2024 that provides ...

Although the company remains quiet about the project, this patent—filed with the United States Patent and Trademark Office (USPTO)—gives some clues as to Samsung’s vision for this next-generation ...